Some studies have suggested that BCR::ABL1 expression alone (or low-level BCR::ABL1 expression) may not be sufficient to trigger CML leukemogenesis [53,54,55,56]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.